Physician profile
Abhin Kumar
NPI 1770013245
$17,302.12
in general payments reported to CMS, 2019-2025
29 companies · $701 in 2025
The $701 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,831 · 2020: $5,365 · 2021: $2,828 · 2022: $1,312 · 2023: $3,093 · 2024: $1,172 · 2025: $701.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,231 · Travel and Lodging: $1,735.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,231.07 |
| Travel and Lodging | $1,734.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gentleman Orthopedic Solutions | $5,192.90 | 2020-2023 | |
| Pinnacle, INC | $2,456.94 | 2019-2020 | |
| Arthrex, INC. | $2,229.48 | 2020-2023 | |
| Stryker Corporation | $1,462.49 | 2019-2025 | Prostep Mica, Variax, Prostep |
| Treace Medical Concepts, INC. | $1,396.50 | 2023 | |
| Organogenesis INC. | $1,090.68 | 2020-2022 | |
| Anika Therapeutics, INC. | $905.18 | 2021 | |
| Kerecis Limited | $436.42 | 2023-2025 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Bone Support INC. | $292.47 | 2024 | Cerament G, Ceramentbone Void Filler |
| Acera Surgical, INC. | $247.05 | 2021-2023 | Restrata Wound Matrix |
| Smith+Nephew, INC. | $242.02 | 2020-2025 | Oasis Micro, Renasys Go V2 Home, Stravix |
| Nevro Corp. | $174.54 | 2022 | |
| Pylant Medical | $130.90 | 2025 | |
| Terumo Medical Corporation | $121.22 | 2024 | Azur Cx Detachable, Angio-Seal |
| Flower Orthopedics Coporation | $114.95 | 2022 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Crossroads Extremity Systems, LLC | $108.11 | 2019 | |
| Cardiovascular Systems INC. | $107.10 | 2022 | |
| Acell, INC. | $101.43 | 2019 | |
| Medline Industries Lp | $97.24 | 2021 | |
| Biotissue Holdings INC. | $85.06 | 2021 | |
| Medtronic, INC. | $75.71 | 2023 | Intellis Adaptivestim |
| Depuy Synthes Sales INC. | $72.88 | 2019 | |
| Convatec INC. | $35.10 | 2023 | |
| Integra Lifesciences Corporation | $34.42 | 2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Kci USA, INC. | $20.87 | 2022 | |
| Amgen INC. | $20.32 | 2024 | Krystexxa |
| Orthofix Medical, INC. | $18.24 | 2021 | |
| Bioventus LLC | $17.46 | 2025 | Exogen Ultrasound Bone Healing System |
| Assertio Therapeutics, INC. | $14.44 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abhin Kumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.